Gabriela Gruia, M.D.
Board Member
Aprea Therapeutics, Inc. (APRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gabriela Gruia, M.D.
Gabriela Gruia, M.D. is recorded as Board Member at Aprea Therapeutics, Inc. (APRE). Aprea Therapeutics, Inc. reported in an 8-K filed May 8, 2023 that Gabriela Gruia, M.D. was appointed Class II director, effective May 5, 2023.
“On May 5, 2023, the Board of Directors (the "Board") of Aprea Therapeutics, Inc. (the "Company") increased the size of the Board from eight to nine directors and appointed Gabriela Gruia, M.D., as a Class II director and new member of the Board to fill the vacancy on the Board, effective immediately, to serve until the Company's 2024 annual meeting of stockholders or until her earlier resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aprea Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Oren Gilad CEO
- Richard Peters, M.D., Ph.D. Chairman, Board Member
- John Hamill CFO
- Scott M. Coiante CFO
- Greg Korbel COO
- Bernd Seizinger Board Member
- Fouad Namouni, M.D. Board Member
- Gabriela Gruia Board Member
- Jean-Pierre Bizzari Board Member
- Marc Duey Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.